Skip to content

Clinical trials

Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Clear all

333 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20022
20037
20044
20054
20065
20079
20088
20092
201014
201112
20122
201314
20148
20157
20165
201712
20189
20198
202032
202129
202225
202329
202424
202522
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed141
Unknown status59
Recruiting56
Terminated30
Active, not recruiting20
Not yet recruiting14
Enrolling by invitation5
Withdrawn5
Available2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)12
Boehringer Ingelheim9
Bristol-Myers Squibb6
National Jewish Health6
National Human Genome Research Institute (NHGRI)5
Peking Union Medical College Hospital5
Assistance Publique - Hôpitaux de Paris4
Erasmus Medical Center4
InterMune4
Kyntra Bio4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis333
Lung Diseases, Interstitial94
Idiopathic Pulmonary Fibrosis88
Lung Diseases35
Pulmonary Disease, Chronic Obstructive29
COVID-1922
Fibrosis21
Hypertension, Pulmonary21
Sarcoidosis18
Scleroderma, Systemic15

Trials

Showing 1 to 25 of 333. Each trial links to its page on Pharma Observatory.

233 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.